endocrinology
Obesity

GLP-1 leads to significant weight loss in obese

The GLP-1 liraglutide can increase weight loss in overweight and obese adults without diabetes when combined with diet and exercise a study published in NEJM shows. In the 56-week double-blind randomised trial of 3,731 overweight adults, patients who received liraglutide 3mg a day lost an average of 8.4 kg, compared with 2.8 kg in the placebo group. And 63% ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic